Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis

Arthritis Research and Therapy

Volumn 15, Issue 1, 2013, Pages

  Dolff, Sebastian ^a,b   Abdulahad, Wayel H ^a   Arends, Suzanne ^a   van Dijk, Marcory C R F ^a   Limburg, Pieter C ^a   Kallenberg, Cees G M ^a   Bijl, Marc ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BIOPSY; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE COUNT; MALE; PROTEINURIA; REMISSION; SEROLOGY; URINE CYTOLOGY; URINE SEDIMENT; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MIDDLE AGED; URINE;

ADULT; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LUPUS NEPHRITIS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED;

EID: 84874229954     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4189     Document Type: Article

References (21)

1. Bono L, Cameron JS, Hicks JA. The very long-term prognosis and complications of lupus nephritis and its treatment. QJM 1999, 92:211-218. 10.1093/qjmed/92.4.211, 10396609.
2. Dolff S, Berden JH, Bijl M. Treatment of lupus nephritis. Expert Rev Clin Immunol 2010, 6:901-911. 10.1586/eci.10.79, 20979555.
3. D'Agati VD, Appel GB, Estes D, Knowles DM, Pirani CL. Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. Kidney Int 1986, 30:573-581. 10.1038/ki.1986.223, 3537453.
4. Berden JH. Lupus nephritis. Kidney Int 1997, 52:538-558. 10.1038/ki.1997.365, 9264014.
5. Balow JE. Clinical presentation and monitoring of lupus nephritis. Lupus 2005, 14:25-30. 10.1191/0961203305lu2055oa, 15732284.
6. Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010, 69:2074-2082. 10.1136/ard.2010.130476, 20724309.
7. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 2001, 59:2156-2163.
8. Abdulahad WH, Kallenberg CG, Limburg PC, Stegeman CA. Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009, 60:2830-2838. 10.1002/art.24747, 19714581.
9. Chan RW, Lai FM, Li EK, Tam LS, Chung KY, Chow KM, Li PK, Szeto CC. Urinary mononuclear cell and disease activity of systemic lupus erythematosus. Lupus 2006, 15:262-267. 10.1191/0961203306lu2287oa, 16761499.
10. Sakatsume M, Xie Y, Ueno M, Obayashi H, Goto S, Narita I, Homma N, Tasaki K, Suzuki Y, Gejyo F. Human glomerulonephritis accompanied by active cellular infiltrates shows effector T cells in urine. J Am Soc Nephrol 2001, 12:2636-2644.
11. Dolff S, Abdulahad WH, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M. Urinary T cells in active lupus nephritis show an effector memory phenotype. Ann Rheum Dis 2010, 69:2034-2041. 10.1136/ard.2009.124636, 20472588.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
13. Petri M, Kasitanon N, Singh S, Link K, Magder L, Bae SC, Hanly JG, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcón GS, Adu D, Avila-Casado C, Bernatsky SR, Bruce IN, Clarke AE, Contreras G, Fine DM, Gladman DD, Gordon C, Kalunian KC, Madaio MP, Rovin BH, Sanchez-Guerrero J, Steinsson K, Aranow C, Balow JE, Buyon JP, Ginzler EM, et al. Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum 2008, 58:1789-1795. 10.1002/art.23802, 18512814.
14. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004, 15:241-250. 10.1097/01.ASN.0000108969.21691.5D, 14747370.
15. Yamada M, Yagita H, Inoue H, Takanashi T, Matsuda H, Munechika E, Kanamaru Y, Shirato I, Tomino Y, Matushima K, Okumura K, Hashimoto H. Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis. Arthritis Rheum 2002, 46:735-740. 10.1002/art.10112, 11920409.
16. Couzi L, Merville P, Deminiere C, Moreau JF, Combe C, Pellegrin JL, Viallard JF, Blanco P. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum 2007, 56:2362-2370. 10.1002/art.22654, 17599764.
17. Enghard P, Humrich JY, Rudolph B, Rosenberger S, Biesen R, Kuhn A, Manz R, Hiepe F, Radbruch A, Burmester GR, Riemekasten G. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Arthritis Rheum 2009, 60:199-206. 10.1002/art.24136, 19116922.
18. Alexopoulos E, Seron D, Hartley RB, Cameron JS. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990, 37:100-109. 10.1038/ki.1990.14, 1967662.
19. Reich HN, Gladman DD, Urowitz MB, Bargman JM, Hladunewich MA, Lou W, Fan SC, Su J, Herzenberg AM, Cattran DC, Wither J, Landolt-Marticorena C, Scholey JW, Fortin PR. Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. Kidney Int 2011, 79:914-920. 10.1038/ki.2010.525, 21248713.
20. Chan RW, Chow KM, Tam LS, Li EK, Wong SM, Li PK, Szeto CC. Can the urine dipstick test reduce the need for microscopy for assessment of systemic lupus erythematosus disease activity?. J Rheumatol 2005, 32:828-831.
21. Gordon C, Jayne D, Pusey C, Adu D, Amoura Z, Aringer M, Ballerin J, Cervera R, Calvo-Alén J, Chizzolini C, Dayer J, Doria A, Ferrario F, Floege J, Guillevin L, Haubitz M, Hiepe F, Houssiau F, Lesavre P, Lightstone L, Meroni P, Meyer O, Moulin B, O'Reilly K, Praga M, Schulze-Koops H, Sinico R, Smith K, Tincani A, Vasconcelos C, et al. European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus 2009, 18:257-263. 10.1177/0961203308100481, 19213865.